Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: A possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'

Modern Pathology

Volumn 17, Issue 8, 2004, Pages 962-972

  Mikami, Yoshiki ^a   Kiyokawa, Takako ^b   Hata, Sakae ^c   Fujiwara, Keiichi ^c   Moriya, Takuya ^d   Sasano, Hironobu ^a   Manabe, Toshiaki ^e   Akahira, Jun Ichi ^a   Ito, Kiyoshi ^a   Tase, Toru ^f   Yaegashi, Nobuo ^a   Sato, Ikuro ^g   Tateno, Hiroo ^g   Naganuma, Hiroshi ^h  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d TOHOKU UNIVERSITY HOSPITAL   (Japan)

^e KYOTO UNIVERSITY HOSPITAL   (Japan)

^f Department of Gynecology ^*

^g Miyagi Cancer Center   (Japan)

^h SENDAI CITY HOSPITAL   (Japan)

Author keywords

Adenoma malignum; Endocervical adenocarcinomas; Gastrointestinal phenotype; HIK1083; LEGH; MUC; P16INK4

Indexed keywords

CELL MARKER; CHROMOGRANIN A; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR; MUCIN 2; MUCIN 6; PROTEIN ANTIBODY; PROTEIN HIK1083; PROTEIN P16; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADENOMA MALIGNUM; ARTICLE; CANCER CYTODIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GASTROINTESTINAL TRACT; GOBLET CELL; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTESTINE METAPLASIA; LOBULAR ENDOCERVICAL GLANDULAR HYPERPLASIA; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYLORIC GLAND METAPLASIA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADENOCARCINOMA; ADENOMA; CHROMOGRANIN A; CHROMOGRANINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GASTRIC MUCIN; GASTRIC MUCOSA; GASTROINTESTINAL NEOPLASMS; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; METAPLASIA; MUCINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEPRILYSIN; UTERINE CERVICAL NEOPLASMS;

EID: 3342927802     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800148     Document Type: Article

References (25)

1. Scully RE, Bonfiglio TA. Histological Typing of Female Genital Tract Tumours. Springer: Berlin, 1994.
2. Ishii K, Hosaka N, Toki T, et al. A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch 1998;432:315-322.
3. Ishihara K, Kurihara M, Goso Y, et al. Peripheral alpha-linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: epitope recognized by a newly characterized monoclonal antibody. Biochem J 1996;318: 409-416.
4. Ishii K, Katsuyama T, Ota H, et al. Cytologic and cytochemical features of adenoma malignum of the uterine cervix, Cancer 1999;87:245-253,
5. Utsugi K, Hirai Y, Takeshima N, et al. Utility of the monoclonal antibody HIK1083 in the diagnosis of adenoma malignum of the uterine cervix. Gynecol Oncol 1999;75:345-348.
6. Mikami Y, Hata S, Fujiwara K, et al. Florid endocervical glandular hyperplasia with intestinal and pyloric gland metaplasia: worrisome benign mimic of "adenoma malignum". Gynecol Oncol 1999;74:504-511.
7. Mikami Y, Hata S, Melamed J, et al. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology 2001;39:364-372.
8. Nucci MR, Clement PB, Young RH. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am J Surg Pathol 1999;23:886-891.
9. Mikami Y, Manabe T. Lobular endocervical glandular hyperplasia represents pyloric gland metaplasia? Am J Surg Pathol 2000;24:323-324 author reply 325-326.
10. Winterford CM, Walsh MD, Leggett BA, et al. Ultra-structural localization of epithelial mucin core proteins in colorectal tissues. J Histochem Cytochem 1999;47:1063-1074.
11. De Bolos C, Garrido M, Real FX. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 1995;109:723-734.
12. Machado JC, Nogueira AM, Carneiro F, et al. Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 2000;190:437-443.
13. Trejdosiewicz LK, Malizia G, Oakes J, et al. Expression of the common acute lymphoblastic leukaemia antigen (CALLA gp100) in the brush border of normal jejunum and jejunum of patients with coeliac disease. J Clin Pathol 1985;38:1002-1006.
14. Riethdorf L, O'Connell JT, Riethdorf S, et al. Differential expression of MUC2 and MUC5AC in benign and malignant glandular lesions of the cervix uteri. Virchows Arch 2000;437:365-371.
15. Savargaonkar PR, Hale RJ, Mutton A, et al. Neuroendocrine differentiation in cervical carcinoma. J Clin Pathol 1996;49:139-141.
16. Chavez-Blanco A, Taja-Chayeb L, Cetina L, et al. Neuroendocrine marker expression in cervical carcinomas of non-small cell type. Int J Gynecol Pathol 2002;21:368-374.
17. INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-891.
18. Riethdorf L, Riethdorf S, Lee KR, et al. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. Hum Pathol 2002;33:899-904.
19. INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2003;27:187-193.
20. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology 2002;41:185-207.
21. McCluggage WG, Sumathi VP, McBride HA, et al. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2002;21:11-15.
22. Kamoi S, AlJuboury MI, Akin MR, et al. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint. Int J Gynecol Pathol 2002;21:217-223.
23. McCluggage WG, Jenkins D. p16 immunoreactivitv may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2003;22:231-235.
24. Gilks CB, Young RH, Aguirre P, et al. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 1989;13:717-729.
25. Kuragaki C, Enomoto T, Ueno Y, et al. Mutations in the STK11 gene characterize minimal deviation adenocarcinoma of the uterine cervix. Lab Invest 2003;83: 35-45.